Thomas Taapken
Director of Finance/CFO at INFLARX N.V.
Net worth: 4 865 $ as of 29/04/2024
Network origin in Thomas Taapken first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Technical University of Berlin
46
| College/University | Other Consumer Services | 46 |
| Subsidiary | Pharmaceuticals: Major | 21 | |
21
| Public Company | Biotechnology | 21 |
| Public Company | Medical Specialties | 17 | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.
10
| Private Company | Investment Managers | 10 |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.
9
| Holding Company | Biotechnology | 9 |
| Public Company | Medical Specialties | 8 | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland.
7
| Holding Company | Biotechnology | 7 |
| Public Company | Biotechnology | 5 | |
elbion AG
 elbion AG Miscellaneous Commercial ServicesCommercial Services elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany.
4
| Extinct | Miscellaneous Commercial Services | 4 |
Scibase AB
3
| Subsidiary | 3 | |
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Taapken via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Chairman Founder Founder Director/Board Member Director/Board Member | |
| SIEMENS AG | Industrial Machinery | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
| VITROLIFE AB | Medical Specialties | Chairman Chairman Director/Board Member | |
| SIEMENS GAMESA RENEWABLE ENERGY, S.A. | Electrical Products | Director/Board Member Chief Operating Officer Chief Operating Officer | |
| University of St. Gallen | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Director of Finance/CFO Sales & Marketing | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Founder Chairman | |
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Chief Executive Officer | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Corporate Officer/Principal Founder | |
| Humboldt-Universität zu Berlin | College/University | Undergraduate Degree Masters Business Admin | |
Synectics Medical AB
 Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Information Technology Services | Chief Executive Officer Corporate Officer/Principal | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Universität Stuttgart | College/University | Graduate Degree Graduate Degree | |
| GHP SPECIALTY CARE AB (PUBL) | Medical/Nursing Services | Chairman Chairman | |
Docpharma NV
 Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Chief Executive Officer Director/Board Member | |
| DHL GROUP | Air Freight/Couriers | Director/Board Member Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
| BOULE DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| SHF COMMUNICATION TECHNOLOGIES AG | Electronic Equipment/Instruments | Chief Executive Officer Chief Operating Officer | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Scibase Intressenter AB | Director/Board Member Corporate Officer/Principal | ||
| BMW AG | Motor Vehicles | Corporate Officer/Principal Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Founder Director/Board Member | |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Exothera SA
 Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| University of Giessen | College/University | Doctorate Degree Undergraduate Degree | |
| University of Liege | College/University | Doctorate Degree Doctorate Degree | |
Shf AG
 Shf AG Industrial MachineryProducer Manufacturing Shf AG develops, manufactures, and trades heat pumps. The private company is based in Ostermundigen, Switzerland. | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| UCB Pharma Oy Finland | Corporate Officer/Principal | ||
Infinion Biopharma Ltd.
 Infinion Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India. | Pharmaceuticals: Major | Director/Board Member | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal | |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Biotechnology | Director/Board Member | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Corporate Officer/Principal | |
| BeCareLink | Director/Board Member | ||
| Biotie Therapies, Inc. | Director/Board Member |
Statistics
International
| Germany | 11 |
| United States | 11 |
| Sweden | 9 |
| Belgium | 8 |
| Switzerland | 6 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 13 |
| Producer Manufacturing | 4 |
| Electronic Technology | 4 |
| Technology Services | 2 |
Operational
| Director/Board Member | 474 |
| Corporate Officer/Principal | 199 |
| Chairman | 132 |
| Chief Executive Officer | 114 |
| Independent Dir/Board Member | 93 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Lennart Eklund | 57 |
| Stefan Yee | 39 |
| Tord Bertil Lendau | 37 |
| Immo Querner | 35 |
| Nicolas Fulpius | 34 |
| Evan S. Melrose | 32 |
| Per Gunnar Ernst Aniansson | 31 |
| William Burns | 27 |
| Carsten Nils Erik Browall | 27 |
| Ismail Kola | 26 |
| Ann Hanham | 26 |
| Guido Magni | 23 |
| David Lemus | 22 |
| Barbro Fridén | 21 |
| Andreas Klingen | 21 |
- Stock Market
- Insiders
- Thomas Taapken
- Company connections
